Publications by authors named "F Sidikou"

New lateral flow tests for the diagnosis of (Nm) (serogroups A, C, W, X, and Y), MeningoSpeed, and (Sp), PneumoSpeed, developed to support rapid outbreak detection in Africa, have shown good performance under laboratory conditions. We conducted an independent evaluation of both tests under field conditions in Burkina Faso and Niger, in 2018-2019. The tests were performed in the cerebrospinal fluid of suspected meningitis cases from health centers in alert districts and compared to reverse transcription polymerase chain reaction tests performed at national reference laboratories (NRLs).

View Article and Find Full Text PDF

West Nile virus (WNV), belonging to the family, causes a mosquito-borne disease and shows great genetic diversity, with at least eight different lineages. The Koutango lineage of WNV (WN-KOUTV), mostly associated with ticks and rodents in the wild, is exclusively present in Africa and shows evidence of infection in humans and high virulence in mice. In 2016, in a context of Rift Valley fever (RVF) outbreak in Niger, mosquitoes, biting midges and sandflies were collected for arbovirus isolation using cell culture, immunofluorescence and RT-PCR assays.

View Article and Find Full Text PDF

Meningococcal meningitis remains a life-threatening disease worldwide, with high prevalence in the sub-Saharan meningitis belt. A rapid diagnosis is crucial for implementing adapted antimicrobial treatment. We describe the performances of a new immunochromatographic test (MeningoSpeed, BioSpeedia, France) for detecting and grouping Cerebrospinal fluids (CSFs) were collected from 5 African countries and France.

View Article and Find Full Text PDF

Background: The MenAfriNet consortium was established in 2014 to support implementation of case-based meningitis surveillance in 5 countries in the meningitis belt of sub-Saharan Africa: Burkina Faso, Chad, Mali, Niger, and Togo. Assessing surveillance performance is critical for interpretation of the collected data and implementation of future surveillance-strengthening initiatives.

Methods: Detailed epidemiologic and laboratory data were collected on suspected meningitis cases through case-based meningitis surveillance in participating districts in 5 countries.

View Article and Find Full Text PDF
Article Synopsis
  • - In 2010, Niger implemented a new vaccine for meningitis, leading to a study analyzing bacterial meningitis cases from 2010 to 2018, confirming 5590 cases out of over 21,000 suspected.
  • - The main bacteria found were Neisseria meningitidis (85%), Streptococcus pneumoniae (13%), and Haemophilus influenzae (2%), with no cases of NmA reported after 2011.
  • - The patterns of meningitis serogroups changed over time, indicating the necessity for ongoing surveillance to adapt vaccine strategies effectively in Niger.
View Article and Find Full Text PDF